Please login to the form below

Not currently logged in

Eisai’s US division promotes Shaji Procida to chief financial officer

Will oversee pharma firm’s financial operations in the US

Shaji Procida - Eisai IncShaji Procida has been named the new VP and chief financial officer of Japanese pharma firm Eisai's US subsidiary.

In her new position, she will oversee all of Eisai Inc's financial operations in the US, as well serving on the company's executive committee.

Procida joined Eisai as its financial consolidations and reporting manager in 1998 and went on to hold various positions in finance and accounting, most recently serving as VP of finance.

"Shaji is a consummate professional who has been a key advisor within our organisation," said Lonnel Coats, president and CEO of Eisai Inc.

"Her expertise and business leadership will continue to ensure our company's financial well-being as well as support our ongoing efforts to achieve our human health care mission of helping to improve the lives of patients and their families."

In addition to her career at Eisai, Procida is also is a member of the Financial Executive Institute and the Healthcare Businesswomen's Association (HBA). In 2006, she was recognised as a 'rising star' by the HBA at its annual Woman of the Year event.

27th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...